Melatonin receptors: Potential targets for central nervous system disorders

Expert Opinion on Investigational Drugs

Volumn 6, Issue 4, 1997, Pages 399-406

  Mahle, C D ^a   Watson, A J ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

adenylyl cyclase; circadian; melatonin; pineal gland; seven transmembrane receptor; sleep

Indexed keywords

2 IODOMELATONIN; ADENYLATE CYCLASE; AGOMELATINE; CYDOT; LUZINDOLE; LY 156735; MELATONIN; MELATONIN DERIVATIVE; MELATONIN RECEPTOR; MELZANE; METHOXYCARBONYLAMINO N ACETYLTRYPTAMINE; N [2 (1 NAPHTHYL)ETHYL]CYCLOBUTANECARBOXAMIDE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL MODEL; CENTRAL NERVOUS SYSTEM DISEASE; CIRCADIAN RHYTHM; CLINICAL TRIAL; DRUG RECEPTOR BINDING; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL RESEARCH; MOLECULAR CLONING; NONHUMAN; PHYSIOLOGY; PINEAL BODY; REVIEW; SLEEP; SLEEP DISORDER;

EID: 0030984265     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.6.4.399     Document Type: Review

References (64)